Dural and Skull Base Metastases

  • Arnaldo Neves Da Silva
  • David Schiff
Part of the Cancer Treatment and Research book series (CTAR, volume 136)


Dural metastases (DM) usually affect patients in late stages of their disease with the majority of them harboring widespread metastatic disease that frequently accounts for the severity of the prognosis. They are also named pachymeningeal metastases and may arise from direct extension from skull metastasis or hematogenous spread from distant sites.


Brain Metastasis Skull Base Temporal Bone Cavernous Sinus Subdural Hematoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Posner J. Intracranial metastasis. In: Posner J, eds. Neurologic Complications of Cancer. F.A. Davis, Philadelphia., 1995:77–110.Google Scholar
  2. 2.
    Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J and Delattre JY. Dural metastases. J Neurooncol 2005;75(1):57–61.PubMedGoogle Scholar
  3. 3.
    Meyer PC, Reath TG. Secondary neoplasms of the central nervous system and meninges. Br J Cancer 1953;7(4):438–48.PubMedGoogle Scholar
  4. 4.
    Lesse S, Netsky MG. Metastasis of neoplasms to the central nervous system and meninges. AMA Arch Neurol Psychiatry 1954;72(2):133–53.PubMedGoogle Scholar
  5. 5.
    Posner JB, Chernik NL. Intracranial metastases from systemic cancer. In: Schoenberg BS, eds. Advances in Neurology. New York, NY: Raven Press, 1978:579–592.Google Scholar
  6. 6.
    Kleinschmidt-DeMasters BK. Dural metastases. A retrospective surgical and autopsy series. Arch Pathol Lab Med 2001;125(7):880–7.PubMedGoogle Scholar
  7. 7.
    France LH. Contribution to the study of 150 cases of cerebral metastases. II. Neuropathological study. J Neurosurg Sci 1975;19(4):189–210.PubMedGoogle Scholar
  8. 8.
    Takakura K, Sano K, Hojo S and Hirano A. Metastatic Tumors of the Central Nervous System. Tokio, Japan: Igaku-Shoin Ltd, 1982.Google Scholar
  9. 9.
    Ahn JY, Kim NK, Oh D and Ahn HJ. Thymic carcinoma with brain metastasis mimicking meningioma. J Neurooncol 2002;58(3):193–9.PubMedGoogle Scholar
  10. 10.
    Bentley AM, Keen JC. Dural metastases in prostate cancer. Clin Oncol (R Coll Radiol) 2003;15(3):165–6.Google Scholar
  11. 11.
    Higuchi M, Fujimoto Y, Miyahara E and Ikeda H. Isolated dural metastasis from colon cancer. Clin Neurol Neurosurg 1997;99(2):135–7.PubMedGoogle Scholar
  12. 12.
    Maezawa H. Dural metastasis of prostatic carcinoma on the middle fossa. No To Shinkei 1998;50(11):1034–5.PubMedGoogle Scholar
  13. 13.
    Maiuri F, Esposito F, Del Basso De Caro, M. and Tortora F. Dural cerebellopontine angle metastasis from malignant parotid oncocytoma. J Neurooncol 2003;61(1):69–72.PubMedGoogle Scholar
  14. 14.
    Oyoshi T, Nakayama M, Hirano H, Shimokawa S and Kuratsu J. Intracranial dural metastasis of mediastinal seminoma–case report. Neurol Med Chir (Tokyo) 2000;40(8):423–6.Google Scholar
  15. 15.
    Tsukada Y, Fouad A, Pickren JW and Lane WW. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 1983;52(12): 2349–54.PubMedGoogle Scholar
  16. 16.
    Scarrow AM, Rajendran PR and Marion D. Metastatic prostate adenocarcinoma of the dura mater. Br J Neurosurg 2000;14(5):473–4.PubMedGoogle Scholar
  17. 17.
    Sgouros S, Walsh AR. Synchronous dural and cutaneous metastases along the distribution of the external carotid artery. Br J Neurosurg 1994;8(5):617–9.PubMedGoogle Scholar
  18. 18.
    Cobo Dols M, Gil Calle S and Villar Chamorro E, et al. Dural metastases with subdural hematoma from prostate cancer. Oncologia 2005;28(8):407–11.Google Scholar
  19. 19.
    Batson OV. The vertebral system of veins as a means for cancer dissemination. Prog Clin Cancer 1967;3:1–18.PubMedGoogle Scholar
  20. 20.
    Tomlin JM, Alleyne CH. Transdural metastasis from adenocarcinoma of the prostate mimicking subdural hematoma: case report. Surg Neurol 2002;58(5):329,31; discussion 331.PubMedGoogle Scholar
  21. 21.
    McKenzie CR, Rengachary SS, McGregor DH, Dixon AY and Suskind DL. Subdural hematoma associated with metastatic neoplasms. Neurosurgery 1990;27(4):619,24; discussion 624–5.PubMedGoogle Scholar
  22. 22.
    Rouah E, Goodman JC and Harper RL. Acute subdural hematoma and metastatic seminoma. Neurology 1986;36(3):418–20.PubMedGoogle Scholar
  23. 23.
    N’dri Oka D, Varlet G, Boni N, Broalet E, Boukassa L and Ba Zeze V. Dural metastasis of prostatic adenocarcinoma presenting as acute intracranial subdural hematoma: a case report. J Neuroradiol 2000;27(4):282–4.PubMedGoogle Scholar
  24. 24.
    Varlet G, N’Dri Oka D, Kakou M, Echimane A and Ba Zeze V. Secondary subdural hematoma in dural metastasis of prostatic adenocarcinoma. Rev Neurol (Paris) 2001;157(12):1543–5.Google Scholar
  25. 25.
    Nagaya T, Doi T and Katsumata T, et al. Subdural hematoma associated with dural carcinomatosis of gastric cancer and DIC. Gan No Rinsho 1986;32(8):923–6.PubMedGoogle Scholar
  26. 26.
    Tasaki K, Shima T and Matsumura S, et al. A case of subdural effusion secondary to dural metastasis of prostatic cancer: case report. No Shinkei Geka 1990;18(6):539–42.PubMedGoogle Scholar
  27. 27.
    Rumana CS, Hess KR, Shi WM and Sawaya R. Metastatic brain tumors with dural extension. J Neurosurg 1998;89(4):552–8.PubMedGoogle Scholar
  28. 28.
    Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology 2000;54(6):1222–6.PubMedGoogle Scholar
  29. 29.
    Nadel L, Braun IF, Muizelaar JP and Laine FJ. Tumoral thrombosis of cerebral venous sinuses: preoperative diagnosis using magnetic resonance phase imaging. Surg Neurol 1991;35(3):189–95.PubMedGoogle Scholar
  30. 30.
    Minette SE, Kimmel DW. Subdural hematoma in patients with systemic cancer. Mayo Clin Proc 1989;64(6):637–42.PubMedGoogle Scholar
  31. 31.
    Kunii N, Morita A, Yoshikawa G and Kirino T. Subdural hematoma associated with dural metastasis–case report–. Neurol Med Chir (Tokyo) 2005;45(10):519–22.Google Scholar
  32. 32.
    Leech RW, Welch FT and Ojemann GA. Subdural hematoma secondary to metastatic dural carcinomatosis. Case report. J Neurosurg 1974;41(5):610–3.PubMedGoogle Scholar
  33. 33.
    Caputi F, Lamaida E and Gazzeri R. Acute subdural hematoma and pachymeningitis carcinomatosa: case report. Rev Neurol (Paris) 1999;155(5):383–5.Google Scholar
  34. 34.
    Russel D.S., Cairns H. Subdural false membrane or hematoma (pachymeningitis interna hemorrhagica) in carcinomatosis and sarcomatosis of the dura mater. Brain 1934;57:32–48.Google Scholar
  35. 35.
    Bucci MN, Farhat SM. Metastatic adenocarcinoma of the prostate as a cause of subdural hematoma. J Urol 1986;135(4):803–4.PubMedGoogle Scholar
  36. 36.
    Turner DM, Graf CJ. Nontraumatic subdural hematoma secondary to dural metastasis: case report and review of the literature. Neurosurgery 1982;11(5):678–80.PubMedGoogle Scholar
  37. 37.
    Cheng CL, Greenberg J and Hoover LA. Prostatic adenocarcinoma metastatic to chronic subdural hematoma membranes. Case report. J Neurosurg 1988;68(4):642–4.PubMedGoogle Scholar
  38. 38.
    Shamim MS, Bari ME and Enam SA. Dural metastases presenting as an extradural hematoma: a rare presentation. J Pak Med Assoc 2005;55(11): 509–10.PubMedGoogle Scholar
  39. 39.
    Weaver DD, Cross DL, Winn HR and Jane JA. Computed tomographic findings in metastatic dural carcinomatosis. Surg Neurol 1984;21(2):190–4.PubMedGoogle Scholar
  40. 40.
    Tyrrell RL 2nd, Bundschuh CV and Modic MT. Dural carcinomatosis: MR demonstration. J Comput Assist Tomogr 1987;11(2):329–32.PubMedGoogle Scholar
  41. 41.
    Johnson MD, Powell SZ, Boyer PJ, Weil RJ and Moots PL. Dural lesions mimicking meningiomas. Hum Pathol 2002;33(12):1211–26.PubMedGoogle Scholar
  42. 42.
    Tagle P, Villanueva P, Torrealba G and Huete I. Intracranial metastasis or meningioma? An uncommon clinical diagnostic dilemma. Surg Neurol 2002;58(3–4):241–5.PubMedGoogle Scholar
  43. 43.
    Auer IA, Auer RN. Metastatic dermatofibrosarcoma protuberans mimicking meningioma. Clin Neuropathol 1998;17(4):190–3.PubMedGoogle Scholar
  44. 44.
    Khalfallah M, Roche PH, Figarrela-Branger D, Malca S and Pellet W. Dural metastases mimicking meningioma. Report of a case. Neurochirurgie 1999;45(3):250–4.PubMedGoogle Scholar
  45. 45.
    Ohba S, Kurokawa R, Yoshida K and Kawase T. Metastatic adenocarcinoma of the dura mimicking petroclival meningioma–case report. Neurol Med Chir (Tokyo) 2004;44(6):317–20.Google Scholar
  46. 46.
    Richiello A, Sparano L, Del Basso De Caro,M.L. and Russo G. Dural metastasis mimicking falx meningioma. Case report. J Neurosurg Sci 2003;47(3):167,71; discussion 171.PubMedGoogle Scholar
  47. 47.
    Quint DJ, McGillicuddy JE. Meningeal metastasis of the cerebellopontine angle demonstrating ‘‘dural tail’’ sign. Can Assoc Radiol J 1994;45(1):40–3.PubMedGoogle Scholar
  48. 48.
    Bendszus M, Warmuth-Metz M, Burger R, Klein R, Tonn JC and Solymosi L. Diagnosing dural metastases: the value of 1H magnetic resonance spectroscopy. Neuroradiology 2001;43(4):285–9.PubMedGoogle Scholar
  49. 49.
    Kremer S, Grand S and Remy C, et al. Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 2004;46(8):642–8.PubMedGoogle Scholar
  50. 50.
    Nathoo N, Ugokwe K and Chang AS, et al. The role of (111)indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas. J Neurooncol 2006;.Google Scholar
  51. 51.
    Vasudev Rao T, Deshpande DH. Malignant subdural effusion. A case report. Acta Neurochir (Wien) 1980;52(1–2):61–5.Google Scholar
  52. 52.
    Kamiya K, Inagawa T and Nagasako R. Chronic subdural hematoma due to dural metastasis: demonstration of adenocarcinoma cell nests in the fluid. Case report. Neurol Med Chir (Tokyo) 1987;27(9):892–8.Google Scholar
  53. 53.
    Chang EL, Lo S. Diagnosis and management of central nervous system metastases from breast cancer. Oncologist 2003;8(5):398–410.PubMedGoogle Scholar
  54. 54.
    Borgelt B, Gelber R and Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6(1):1–9.PubMedGoogle Scholar
  55. 55.
    Khuntia D, Brown P, Li J and Mehta MP. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006;24(8):1295–304.PubMedGoogle Scholar
  56. 56.
    Saito EY, Viani GA and Ferrigno R, et al. Whole brain radiation therapy in management of brain metastasis: results and prognostic factors. Radiat Oncol 2006;1:20.PubMedGoogle Scholar
  57. 57.
    Cavaliere R, Schiff D. Cerebral metastases–a therapeutic update. Nat Clin Pract Neurol 2006;2(8):426–36.PubMedGoogle Scholar
  58. 58.
    Gaspar LE, Scott C, Murray K and Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000;47(4):1001–6.PubMedGoogle Scholar
  59. 59.
    Jansen BPW, Sillevis Smitt PAE. Skull and dural metastases. In: Schiff D, Wen PY, ed. Cancer Neurology in Clinical Practice. Humana Press Inc., 2002:87–92.Google Scholar
  60. 60.
    Greenberg HS, Deck MD, Vikram B, Chu FC and Posner JB. Metastasis to the base of the skull: clinical findings in 43 patients. Neurology 1981;31(5):530–7.PubMedGoogle Scholar
  61. 61.
    Laigle-Donadey F, Taillibert S, Martin-Duverneuil N, Hildebrand J and Delattre JY. Skull base metastases. J Neurooncol 2005;75(1):63–9.PubMedGoogle Scholar
  62. 62.
    Long MA, Husband JE. Features of unusual metastases from prostate cancer. Br J Radiol 1999;72(862):933–41.PubMedGoogle Scholar
  63. 63.
    DeMonte F, Hanbali F. and Ballo M.T. Skull base metastasis. In: Berger M.S., Prados M.D., ed. Textbook of Neuro-Oncology. 1st ed. Philadelphia: Elsevier Saunders, 2005:466–475.Google Scholar
  64. 64.
    Castaldo JE, Bernat JL, Meier FA and Schned AR. Intracranial metastases due to prostatic carcinoma. Cancer 1983;52(9):1739–47.PubMedGoogle Scholar
  65. 65.
    Svare A, Fossa SD and Heier MS. Cranial nerve dysfunction in metastatic cancer of the prostate. Br J Urol 1988;61(5):441–4.PubMedGoogle Scholar
  66. 66.
    Batson OV. The function of the vertebral veins and their role in the spread of metastases. 1940. Clin Orthop Relat Res 1995;(312)(312):4–9.PubMedGoogle Scholar
  67. 67.
    Rubinstein MK. Cranial mononeuropathy as the first sign of intracranial metastases. Ann Intern Med 1969;70(1):49–54.PubMedGoogle Scholar
  68. 68.
    Massey EW, Moore J and Schold SC, Jr. Mental neuropathy from systemic cancer. Neurology 1981;31(10):1277–81.PubMedGoogle Scholar
  69. 69.
    Stark AM, Eichmann T and Mehdorn HM. Skull metastases: clinical features, differential diagnosis, and review of the literature. Surg Neurol 2003;60(3):219,25; discussion 225–6.PubMedGoogle Scholar
  70. 70.
    Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit II. A clinicopathological study of 26 patients with carcinoma metastatic to the anterior segment of the eye. Arch Ophthalmol 1975;93(7):472–82.PubMedGoogle Scholar
  71. 71.
    Font RL, Ferry AP. Carcinoma metastatic to the eye and orbit III. A clinicopathologic study of 28 cases metastatic to the orbit. Cancer 1976;38(3): 1326–35.PubMedGoogle Scholar
  72. 72.
    Boldt HC, Nerad JA. Orbital metastases from prostate carcinoma. Arch Ophthalmol 1988;106(10):1403–8.PubMedGoogle Scholar
  73. 73.
    Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch Ophthalmol 1974;92(4):276–86.PubMedGoogle Scholar
  74. 74.
    Ferry AP, Font RL. Carcinoma metastatic to the orbit. Mod Probl Ophthalmol 1975;14:377–81.PubMedGoogle Scholar
  75. 75.
    Sacks JG, O’Grady RB. Painful ophthalmoplegia and enophthalmos due to metastatic carcinoma: simulation of essential facial hemiatrophy. Trans Am Acad Ophthalmol Otolaryngol 1971;75(2):351–4.PubMedGoogle Scholar
  76. 76.
    Yi HJ, Kim CH, Bak KH, Kim JM, Ko Y and Oh SJ. Metastatic tumors in the sellar and parasellar regions: clinical review of four cases. J Korean Med Sci 2000;15(3):363–7.PubMedGoogle Scholar
  77. 77.
    Branch CL,Jr, Laws ER,Jr. Metastatic tumors of the sella turcica masquerading as primary pituitary tumors. J Clin Endocrinol Metab 1987;65(3):469–74.PubMedGoogle Scholar
  78. 78.
    Roessmann U, Kaufman B and Friede RL. Metastatic lesions in the sella turcica and pituitary gland. Cancer 1970;25(2):478–80.PubMedGoogle Scholar
  79. 79.
    Julien J, Ferrer X, Drouillard J, Philippe JC and Desbordes P. Cavernous sinus syndrome due to lymphoma. J Neurol Neurosurg Psychiatry 1984;47(5): 558–60.PubMedGoogle Scholar
  80. 80.
    Mills RP, Insalaco SJ and Joseph A. Bilateral cavernous sinus metastasis and ophthalmoplegia. Case report. J Neurosurg 1981;55(3):463–6.PubMedGoogle Scholar
  81. 81.
    Johnston JL. Parasellar syndromes. Curr Neurol Neurosci Rep 2002;2(5): 423–31.PubMedGoogle Scholar
  82. 82.
    Bitoh S, Hasegawa H, Obashi J and Maruno M. Secondary malignancies involving parasellar region: clinical manifestations, diagnosis and management in 16 patients. Med J Osaka Univ 1985;36(1–2):17–27.PubMedGoogle Scholar
  83. 83.
    Bitoh S, Hasegawa H, Ohtsuki H, Obashi J and Kobayashi Y. Parasellar metastases: four autopsied cases. Surg Neurol 1985;23(1):41–8.PubMedGoogle Scholar
  84. 84.
    Posner JB. Cancer involving cranial and peripheral nerves. In: Posner JB, eds. Neurologic Complications of Cancer. Philadelphia: FA Davis, 1995:172–184.Google Scholar
  85. 85.
    Maddox HE 3rd. Metastatic tumors of the temporal bone. Ann Otol Rhinol Laryngol 1967;76(1):149–65.PubMedGoogle Scholar
  86. 86.
    Hirota N, Fujimoto T, Takahashi M and Fukushima Y. Isolated trigeminal nerve metastases from breast cancer: an unusual cause of trigeminal mononeuropathy. Surg Neurol 1998;49(5):558–61.PubMedGoogle Scholar
  87. 87.
    Leggett CA. Metastases from carcinoma of the breast involving the central nervous system. Aust N Z J Surg 1989;59(3):235–42.PubMedGoogle Scholar
  88. 88.
    Delaney P, Khoa N and Saini N. Isolated trigeminal neuropathy. An unusual complication of carcinoma of the lung. JAMA 1977;237(23):2522–3.PubMedGoogle Scholar
  89. 89.
    Shine NP, O’Sullivan P. Collet-Sicard syndrome: a rare presentation of metastatic prostate adenocarcinoma. Auris Nasus Larynx 2005;32(3):315–8.PubMedGoogle Scholar
  90. 90.
    Wilson H, Johnson DH. Jugular foramen syndrome as a complication of metastatic cancer of the prostate. South Med J 1984;77(1):92–3.PubMedGoogle Scholar
  91. 91.
    Graus F, Slatkin NE. Papilledema in the metastatic jugular foramen syndrome. Arch Neurol 1983;40(13):816–8.PubMedGoogle Scholar
  92. 92.
    Nagata H, Sato S and Tanaka K, et al. Skull base metastasis of the breast cancer causing the Collet-Sicard syndrome–a case report (author’s transl). No To Shinkei 1980;32(7):695–700.PubMedGoogle Scholar
  93. 93.
    Schweinfurth JM, Johnson JT and Weissman J. Jugular foramen syndrome as a complication of metastatic melanoma. Am J Otolaryngol 1993;14(3):168–74.PubMedGoogle Scholar
  94. 94.
    Chacon G, Alexandraki I and Palacio C. Collet-sicard syndrome: an uncommon manifestation of metastatic prostate cancer. South Med J 2006;99(8):898–9.PubMedGoogle Scholar
  95. 95.
    Satoh H, Nishiyama T, Horiguchi A, Nakashima J, Saito S and Murai M. A case of Collet-Sicard syndrome caused by skull base metastasis of prostate carcinoma. Nippon Hinyokika Gakkai Zasshi 2000;91(6):562–4.PubMedGoogle Scholar
  96. 96.
    Gloria-Cruz TI, Schachern PA, Paparella MM, Adams GL and Fulton SE. Metastases to temporal bones from primary nonsystemic malignant neoplasms. Arch Otolaryngol Head Neck Surg 2000;126(2):209–14.PubMedGoogle Scholar
  97. 97.
    Berlinger NT, Koutroupas S, Adams G and Maisel R. Patterns of involvement of the temporal bone in metastatic and systemic malignancy. Laryngoscope 1980;90(4):619–27.PubMedGoogle Scholar
  98. 98.
    Saldanha CB, Bennett JD, Evans JN and Pambakian H. Metastasis to the temporal bone, secondary to carcinoma of the bladder. J Laryngol Otol 1989;103(6):599–601.PubMedGoogle Scholar
  99. 99.
    Saito H, Chinzei K and Furuta M. Pathological features of peripheral facial paralysis caused by malignant tumour. Acta Otolaryngol Suppl 1988;446: 165–71.PubMedGoogle Scholar
  100. 100.
    Miro Castillo N, Roca-Ribas Serda F, Barnadas Molins A, Prades Marti J, Casamitjana Claramunt F and Perello Scherdel E. Facial paralysis of metastatic origin. Review of metastatic lesions of the temporal bone. An Otorrinolaringol Ibero Am 2000;27(3):255–63.PubMedGoogle Scholar
  101. 101.
    Nagai M, Yamada H and Kitamoto M, et al. Facial nerve palsy due to temporal bone metastasis from hepatocellular carcinoma. J Gastroenterol Hepatol 2005;20(7):1131–2.PubMedCrossRefGoogle Scholar
  102. 102.
    Weiss MD, Kattah JC, Jones R and Manz HJ. Isolated facial nerve palsy from metastasis to the temporal bone: report of two cases and a review of the literature. Am J Clin Oncol 1997;20(1):19–23.PubMedGoogle Scholar
  103. 103.
    Marzo SJ, Leonetti JP and Petruzzelli G. Facial paralysis caused by malignant skull base neoplasms. Neurosurg Focus 2002;12(5):e2.PubMedGoogle Scholar
  104. 104.
    Lan MY, Shiao AS and Li WY. Facial paralysis caused by metastasis of breast carcinoma to the temporal bone. J Chin Med Assoc 2004;67(11):587–90.PubMedGoogle Scholar
  105. 105.
    Jung TT, Jun BH, Shea D and Paparella MM. Primary and secondary tumors of the facial nerve. A temporal bone study. Arch Otolaryngol Head Neck Surg 1986;112(12):1269–73.PubMedGoogle Scholar
  106. 106.
    Schuknecht HF, Allam AF and Murakami Y. Pathology of secondary malignant tumors of the temporal bone. Ann Otol Rhinol Laryngol 1968;77(1):5–22.PubMedGoogle Scholar
  107. 107.
    Capobianco DJ, Brazis PW, Rubino FA and Dalton JN. Occipital condyle syndrome. Headache 2002;42(2):142–6.PubMedGoogle Scholar
  108. 108.
    Combarros O, Alvarez de Arcaya A and Berciano J. Isolated unilateral hypoglossal nerve palsy: nine cases. J Neurol 1998;245(2):98–100.PubMedGoogle Scholar
  109. 109.
    Endo K, Okano R, Kuroda Y, Yamada S and Tabei K. Renal cell carcinoma with skull base metastasis preceded by paraneoplastic signs in a chronic hemodialysis patient. Intern Med 2001;40(9):924–30.PubMedGoogle Scholar
  110. 110.
    Moris G, Roig C, Misiego M, Alvarez A, Berciano J and Pascual J. The distinctive headache of the occipital condyle syndrome: a report of four cases. Headache 1998;38(4):308–11.PubMedGoogle Scholar
  111. 111.
    Pascual J, Gutierrez A, Polo JM and Berciano J. Occipital condyle syndrome: presentation of a case. Neurologia 1989;4(8):293–5.PubMedGoogle Scholar
  112. 112.
    Pavithran K, Doval DC, Hukku S and Jena A. Isolated hypoglossal nerve palsy due to skull base metastasis from breast cancer. Australas Radiol 2001;45(4):534–5.PubMedGoogle Scholar
  113. 113.
    Romero M, Paradas C and Torrecilla MD. Isolated paralysis of the hypoglossal nerve due to metastasis at the base of the cranium. Neurologia 2000;15(1):31.PubMedGoogle Scholar
  114. 114.
    Rotta FT, Romano JG. Skull base metastases causing acute bilateral hypoglossal nerve palsy. J Neurol Sci 1997;148(1):127–9.PubMedGoogle Scholar
  115. 115.
    Marinella MA. Metastatic large cell lung cancer presenting with numb chin syndrome. Respir Med 1997;91(4):235–6.PubMedGoogle Scholar
  116. 116.
    Kapa Baskaran R, Ramanarayanan K and Smith M. Numb Chin Syndrome-A reflection of systemic malignancy. World J Surg Oncol 2006;4(1):52.Google Scholar
  117. 117.
    Laurencet FM, Anchisi S, Tullen E and Dietrich PY. Mental neuropathy: report of five cases and review of the literature. Crit Rev Oncol Hematol 2000;34(1):71–9.PubMedGoogle Scholar
  118. 118.
    Burt RK, Sharfman WH, Karp BI and Wilson WH. Mental neuropathy (numb chin syndrome). A harbinger of tumor progression or relapse. Cancer 1992;70(4):877–81.PubMedGoogle Scholar
  119. 119.
    Lossos A, Siegal T. Numb chin syndrome in cancer patients: etiology, response to treatment, and prognostic significance. Neurology 1992;42(6): 1181–4.PubMedGoogle Scholar
  120. 120.
    Horton J, Means ED, Cunningham TJ and Olson KB. The numb chin in breast cancer. J Neurol Neurosurg Psychiatry 1973;36(2):211–6.PubMedGoogle Scholar
  121. 121.
    Lesnick JA, Zallen RD. Numb chin syndrome secondary to metastatic breast disease. J Colo Dent Assoc 1999;78(1):11–4.PubMedGoogle Scholar
  122. 122.
    Myall RW, Morton TH and Worthington P. Melanoma metastatic to the mandible. Report of a case. Int J Oral Surg 1983;12(1):56–9.PubMedGoogle Scholar
  123. 123.
    Halachmi S, Madeb R, Madjar S, Wald M, River Y and Nativ O. Numb chin syndrome as the presenting symptom of metastatic prostate carcinoma. Urology 2000;55(2):286.PubMedGoogle Scholar
  124. 124.
    Aung TH, Po YC and Wong WK. Hepatocellular carcinoma with metastasis to the skull base, pituitary gland, sphenoid sinus, and cavernous sinus. Hong Kong Med J 2002;8(1):48–51.PubMedGoogle Scholar
  125. 125.
    Kistler M, Pribram HW. Metastatic disease of the sella turcica. Am J Roentgenol Radium Ther Nucl Med 1975;123(1):13–21.PubMedGoogle Scholar
  126. 126.
    Komninos J, Vlassopoulou V and Protopapa D, et al. Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 2004;89(2):574–80.PubMedGoogle Scholar
  127. 127.
    McCormick PC, Post KD, Kandji AD and Hays AP. Metastatic carcinoma to the pituitary gland. Br J Neurosurg 1989;3(1):71–9.PubMedGoogle Scholar
  128. 128.
    Branch CL, Jr, Laws ER, Jr. Metastatic tumors of the sella turcica masquerading as primary pituitary tumors. J Clin Endocrinol Metab 1987;65(3):469–74.PubMedGoogle Scholar
  129. 129.
    Morita A, Meyer FB and Laws ER, Jr. Symptomatic pituitary metastases. J Neurosurg 1998;89(1):69–73.PubMedGoogle Scholar
  130. 130.
    Schubiger O, Haller D. Metastases to the pituitary–hypothalamic axis. An MR study of 7 symptomatic patients. Neuroradiology 1992;34(2):131–4.PubMedGoogle Scholar
  131. 131.
    Harzallah L, Migaw H, Harzallah F and Kraiem C. Diabetes insipidus and panhypopituitarism revealing pituitary metastasis of small cell lung carcinoma: a case report. Ann Endocrinol (Paris) 2005;66(2 Pt 1):117–20.Google Scholar
  132. 132.
    Ginsberg LE. Neoplastic diseases affecting the central skull base: CT and MR imaging. AJR Am J Roentgenol 1992;159(3):581–9.PubMedGoogle Scholar
  133. 133.
    Glenn LW. Innovations in neuroimaging of skull base pathology. Otolaryngol Clin North Am 2005;38(4):613–29.PubMedGoogle Scholar
  134. 134.
    Durden DD, Williams DW, 3rd. Radiology of skull base neoplasms. Otolaryngol Clin North Am 2001;34(6):1043,64, vii.Google Scholar
  135. 135.
    Franca C, Levin-Plotnik D, Sehgal V, Chen GT and Ramsey RG. Use of three-dimensional spiral computed tomography imaging for staging and surgical planning of head and neck cancer. J Digit Imaging 2000;13(2 Suppl 1):24–32.PubMedGoogle Scholar
  136. 136.
    Post MJ, Mendez DR, Kline LB, Acker JD and Glaser JS. Metastatic disease to the cavernous sinus: clinical syndrome and CT diagnosis. J Comput Assist Tomogr 1985;9(1):115–20.PubMedGoogle Scholar
  137. 137.
    Yoshizumi K, Korogi Y and Sugahara T, et al. Skull base tumors: evaluation with contrast-enhanced MP-RAGE sequence. Comput Med Imaging Graph 2001;25(1):23–31.PubMedGoogle Scholar
  138. 138.
    Ishida H, Mohri M and Amatsu M. Invasion of the skull base by carcinomas: histopathologically evidenced findings with CT and MRI. Eur Arch Otorhinolaryngol 2002;259(10):535–9.PubMedGoogle Scholar
  139. 139.
    Brillman J, Valeriano J and Adatepe MH. The diagnosis of skull base metastases by radionuclide bone scan. Cancer 1987;59(11):1887–91.PubMedGoogle Scholar
  140. 140.
    Fukumoto M, Osaki Y and Yoshida D, et al. Dual-isotope SPECT diagnosis of a skull base metastasis causing isolated unilateral hypoglossal nerve palsy. Ann Nucl Med 1998;12(4):213–6.PubMedGoogle Scholar
  141. 141.
    Fukui MB, Blodgett TM and Meltzer CC. PET/CT imaging in recurrent head and neck cancer. Semin Ultrasound CT MR 2003;24(3):157–63.PubMedGoogle Scholar
  142. 142.
    Ganly I, Patel SG and Singh B, et al. Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study. Head Neck 2005;27(6):445–51.PubMedGoogle Scholar
  143. 143.
    Ganly I, Patel SG and Singh B, et al. Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study. Arch Otolaryngol Head Neck Surg 2006;132(1):73–8.PubMedGoogle Scholar
  144. 144.
    Patel SG, Singh B and Polluri A, et al. Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer 2003;98(6):1179–87.PubMedGoogle Scholar
  145. 145.
    Carrillo JF, Rivas Leon B, Celis MA, Ponce-de-Leon S and Ochoa-Carrillo FJ. Anterolateral and lateral skull base approaches for treatment of neoplastic diseases. Am J Otolaryngol 2004;25(1):58–67.PubMedGoogle Scholar
  146. 146.
    Jia G, Zhang J and Wu Z. Diagnosis and treatment of skull base metastasis. Zhonghua Yi Xue Za Zhi 1998;78(10):761–2.PubMedGoogle Scholar
  147. 147.
    Hanbali F., DeMonte F. Metastatic tumors of the skull base. In: Sawaya R, eds. Intracranial Metastases: Current Management Strategies. Elmsford, NY: Blackwell/Futura, 2004.Google Scholar
  148. 148.
    Vikram B, Chu FC. Radiation therapy for metastases to the base of the skull. Radiology 1979;130(2):465–8.PubMedGoogle Scholar
  149. 149.
    Ampil FL. Palliative radiation therapy for metastases in base of skull and cranial nerves. Acta Oncol 1988;27(3):293–4.PubMedGoogle Scholar
  150. 150.
    Ransom DT, Dinapoli RP and Richardson RL. Cranial nerve lesions due to base of the skull metastases in prostate carcinoma. Cancer 1990;65(3):586–9.PubMedGoogle Scholar
  151. 151.
    Francel PC, Bhattacharjee S and Tompkins P. Skull base approaches and gamma knife radiosurgery for multimodality treatment of skull base tumors. J Neurosurg 2002;97(5 Suppl):674–6.PubMedGoogle Scholar
  152. 152.
    Miller RC, Foote RL and Coffey RJ, et al. The role of stereotactic radiosurgery in the treatment of malignant skull base tumors. Int J Radiat Oncol Biol Phys 1997;39(5):977–81.PubMedGoogle Scholar
  153. 153.
    Cmelak AJ, Cox RS, Adler JR, Fee WE,Jr and Goffinet DR. Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1997;37(5):997–1003.PubMedGoogle Scholar
  154. 154.
    Iwai Y, Yamanaka K. Gamma Knife radiosurgery for skull base metastasis and invasion. Stereotact Funct Neurosurg 1999;72 Suppl 1:81–7.PubMedGoogle Scholar
  155. 155.
    Iwai Y, Yamanaka K and Yoshimura M. Gamma knife radiosurgery for cavernous sinus metastases and invasion. Surg Neurol 2005;64(5):406,10; discussion 410.PubMedGoogle Scholar
  156. 156.
    Kocher M, Voges J, Staar S, Treuer H, Sturm V and Mueller RP. Linear accelerator radiosurgery for recurrent malignant tumors of the skull base. Am J Clin Oncol 1998;21(1):18–22.PubMedGoogle Scholar
  157. 157.
    Seymore CH, Peeples WJ. Cranial nerve involvement with carcinoma of prostate. Urology 1988;31(3):211–3.PubMedGoogle Scholar
  158. 158.
    Hall SM, Buzdar AU and Blumenschein GR. Cranial nerve palsies in metastatic breast cancer due to osseous metastasis without intracranial involvement. Cancer 1983;52(1):180–4.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Arnaldo Neves Da Silva
    • 1
  • David Schiff
    • 1
  1. 1.Neurology Department, Division of Neuro-OncologyUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations